Skip Navigation or Skip to Content
Blog Author
Tenthpin

California’s Low-Cost Insulin Is Symptom Of Lifesaving Innovations To Come

Featured image: California’s Low-Cost Insulin Is Symptom Of Lifesaving Innovations To Come

Susan Galer has published on Forbes covering the SAP Life Sciences event, featuring remarks from Michael Schmidt’s excellent trends session.

Read the full article here

screenshot_2022-07-25_at_11.52.3

screenshot_2022-07-25_at_11.53.0

screenshot_2022-07-25_at_11.53.2

screenshot_2022-07-25_at_11.53.4

screenshot_2022-07-25_at_11.54.1

Share This Blog

Related insights

Reporting of revenue has been a required necessity since the beginning of accounting for business operations. The goal of...

E-invoicing is a fast-approaching reality for Life Sciences companies. What was once a finance efficiency topic has become a...

Purpose-built Product Lifecycle Management (PLM) solutions accelerate innovation while ensuring regulatory compliance and...

We are a globally leading business and technology boutique consultancy for the Life Sciences industry. Our clients are leading companies from pharma, biotech, med tech, healthcare & animal health.

© 2026 Tenthpin AG | Illustrations by: www.till-lauer.ch